PMID: 6973985Jan 1, 1981Paper

Renal function and laboratory safety parameters after two weeks' administration of fluproquazone to man

Arzneimittel-Forschung
M Crawford, G Thiel

Abstract

When 4-(p-fluorophenyl)-1-isopropyl-7-methyl-2(1H)-quinazolinone (fluproquazone) was given for 14 days (100 mg t.i.d.) to six healthy male volunteers, it produced no clinically relevant effects upon the subjects' renal function, urine microscopic findings, blood coagulation status, or upon their general well-being as shown by a range of laboratory safety tests including haematological profile and blood and urine biochemistry. Minor and transient side effects mainly affecting the gastrointestinal system were seen in four subjects.

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.